Unavailable
Unavailable
Save time and jump to the most important pieces.
Ampco-Pittsburgh Corporation (NYSE:AP) will hold a conference call on Tuesday, May 13, 2025, at 10:30 a.m. Eastern Time (ET) to discuss its financial results for the first quarter ended March 31, 2025. If you would like to participate in the conference call, please register using the link below or by dialing 1-844-308-3408 at least five minutes before the 10:30 a.m. ET start time. We encourage participants to pre-register for the conference call using the following link. Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the call
Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Robert A. DeMichiei to its board of directors. A seasoned leader with over 30 years of experience in financial strategy, healthcare operations, and board governance, Mr. DeMichiei served as executive vice president and chief financial officer at the University of Pittsburgh Medical Center (UPMC) from 2004 to 2020. During his tenure, he played a pivotal role in driving UPMC's financial growth and led numerous strategic initiatives, including mergers and acquisitions, supply chain management, and revenue cycle improvements. Prior to joining U
Reported earnings per common share of approximately $0.16 for 4Q 2024 and $0.02 for full year 2024. Net cash flows provided by operating activities of $7.5 million for 4Q 2024 and $18.0 million for full year 2024. 2024 full year income from operations of $12.2 million includes a $4.1 million non-cash asbestos-related revaluation benefit recorded in Q4 2024. 2024 full year non-GAAP adjusted income from operations of $8.0 million improved $3.7 million vs 2023. Record Air and Liquid Processing segment sales in 2024. Segment sales increased 6.5% for 4Q 2024 and 11% for 2024 full year compared to prior year periods. Exploring options to mitigate losses in underutilized cast roll opera
DEF 14A - AMPCO PITTSBURGH CORP (0000006176) (Filer)
10-K - AMPCO PITTSBURGH CORP (0000006176) (Filer)
8-K - AMPCO PITTSBURGH CORP (0000006176) (Filer)
4 - AMPCO PITTSBURGH CORP (0000006176) (Issuer)
4 - AMPCO PITTSBURGH CORP (0000006176) (Issuer)
SC 13D/A - AMPCO PITTSBURGH CORP (0000006176) (Subject)
SC 13D/A - AMPCO PITTSBURGH CORP (0000006176) (Subject)
SC 13D/A - AMPCO PITTSBURGH CORP (0000006176) (Subject)
4 - AMPCO PITTSBURGH CORP (0000006176) (Issuer)
4 - AMPCO PITTSBURGH CORP (0000006176) (Issuer)
4 - AMPCO PITTSBURGH CORP (0000006176) (Issuer)
Ampco-Pittsburgh Corporation (NYSE:AP) will hold a conference call on Tuesday, May 13, 2025, at 10:30 a.m. Eastern Time (ET) to discuss its financial results for the first quarter ended March 31, 2025. If you would like to participate in the conference call, please register using the link below or by dialing 1-844-308-3408 at least five minutes before the 10:30 a.m. ET start time. We encourage participants to pre-register for the conference call using the following link. Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the call
Reported earnings per common share of approximately $0.16 for 4Q 2024 and $0.02 for full year 2024. Net cash flows provided by operating activities of $7.5 million for 4Q 2024 and $18.0 million for full year 2024. 2024 full year income from operations of $12.2 million includes a $4.1 million non-cash asbestos-related revaluation benefit recorded in Q4 2024. 2024 full year non-GAAP adjusted income from operations of $8.0 million improved $3.7 million vs 2023. Record Air and Liquid Processing segment sales in 2024. Segment sales increased 6.5% for 4Q 2024 and 11% for 2024 full year compared to prior year periods. Exploring options to mitigate losses in underutilized cast roll opera
Ampco-Pittsburgh Corporation (NYSE:AP) will hold a conference call on Thursday, March 13, 2025, at 10:30 a.m. Eastern Time (ET) to discuss its financial results for the fourth quarter ended December 31, 2024. If you would like to participate in the conference call, please register using the link below or by dialing 1-844-308-3408 at least five minutes before the 10:30 a.m. ET start time. We encourage participants to pre-register for the conference call using the following link. Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after
Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Robert A. DeMichiei to its board of directors. A seasoned leader with over 30 years of experience in financial strategy, healthcare operations, and board governance, Mr. DeMichiei served as executive vice president and chief financial officer at the University of Pittsburgh Medical Center (UPMC) from 2004 to 2020. During his tenure, he played a pivotal role in driving UPMC's financial growth and led numerous strategic initiatives, including mergers and acquisitions, supply chain management, and revenue cycle improvements. Prior to joining U
Enters into Cooperation Agreement with Ancora Ampco-Pittsburgh Corporation (NYSE:AP) ("Ampco-Pittsburgh" or the "Corporation") today announced that it has appointed three independent directors to its Board of Directors (the "Board"), two of whom were appointed in connection with an agreement with Ancora Holdings Group, LLC (together with its affiliates, "Ancora"), a shareholder which currently owns approximately 5.6% of the Corporation's outstanding shares. Frederick D. DiSanto and Darrell L. McNair will join the Board as members of the class of directors to be elected at the 2023 Annual Meeting of the Corporation's shareholders, effective immediately pursuant to a Cooperation Agreement en
Ampco-Pittsburgh Corporation (NYSE:AP) (the "Corporation" or "Ampco-Pittsburgh") today announced the appointment of David G. Anderson as President of Air & Liquid Systems Corporation ("Air & Liquid Systems"), a wholly-owned subsidiary of Ampco-Pittsburgh, effective January 1, 2022. Mr. Anderson succeeds Terrence W. Kenny, who has served as Air & Liquid Systems' President since 2010 and has announced his retirement. Brett McBrayer, Chief Executive Officer of the Corporation, stated, "Terry's retirement will cap more than three decades of achievement and growth. He and his valued leadership will be greatly missed. On behalf of the Board and the Corporation, I would like to thank Terry for hi